Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia

The ever increasing interventional CVD outcome studies have resulted in statins being an essential factor of cardiovascular prevention strategies. The JUPITER study in 2008, despite reducing CVD and overall mortality, highlighted an increase in new onset diabetes in the rosuvastatin treated arm. Sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Ahmed, Milles, John, Ramachandran, Sudarshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411536/
https://www.ncbi.nlm.nih.gov/pubmed/22879796
http://dx.doi.org/10.4137/CMED.S7591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411536/
https://www.ncbi.nlm.nih.gov/pubmed/22879796
http://dx.doi.org/10.4137/CMED.S7591

Ejemplares similares